Kidney transplant recipients are at increased risk for development of malignancy compared with the general population, and malignancies occur at an earlier age. This increased risk, as expressed by the standard incidence ratio (SIR), varies widely, but it is highest in malignancies triggered by oncogenic viruses. For other cancers, this increased risk is the direct consequence of immunosuppressants promoting tumor growth and lowering immune system tumor surveillance. In this review, we briefly discuss the common malignancies with increased risk after kidney transplantation, explore the pros and cons associated with screening, and summarize current prevention and treatment recommendations. © 2014 National Kidney Foundation, Inc.
CITATION STYLE
Asch, W. S., & Bia, M. J. (2014, January). Oncologic Issues and Kidney Transplantation: A Review of Frequency, Mortality, and Screening. Advances in Chronic Kidney Disease. https://doi.org/10.1053/j.ackd.2013.07.003
Mendeley helps you to discover research relevant for your work.